Tang Capital Management LLC raised its holdings in shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) by 45.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 200,000 shares of the biotechnology company’s stock after purchasing an additional 62,300 shares during the […]
Banque Pictet & Cie SA reduced its holdings in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) by 24.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,851 shares of the biotechnology company’s stock after selling 5,317 shares during the quarter. Banque Pictet […]
Nisa Investment Advisors LLC lessened its position in shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) by 22.5% in the third quarter, Holdings Channel.com reports. The fund owned 936 shares of the biotechnology company’s stock after selling 271 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Enanta Pharmaceuticals were worth $42,000 at […]
Russell Investments Group Ltd. raised its position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) by 2.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,324 shares of the biotechnology company’s stock after purchasing an additional 603 shares during the quarter. Russell Investments […]
SG Americas Securities LLC cut its holdings in shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) by 8.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,868 shares of the biotechnology company’s stock after selling 2,153 shares during the […]